Atlas Trials

AZA Combined With RCHOP in P53-mutated DLBCL.

Clinical trial NCT06158399 · RECRUITING

Trial details

NCT number
NCT06158399
Sponsor
The First Affiliated Hospital of Xiamen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DLBCL - Diffuse Large B Cell LymphomaTP53
Start date
2023-11-22
Primary completion
2026-05-31
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.